Sign Up to like & get
recommendations!
3
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.826411
Abstract: While triggering oocyte maturation with GnRH agonist (GnRHa) seems to be safe and effective in terms of the risk of developing OHSS and the number of metaphase II oocytes, it nevertheless results in luteal phase…
read more here.
Keywords:
gnrha;
day oocyte;
outcome;
hcg day ... See more keywords